| Date Initiated by Firm | October 29, 2004 |
| Date Posted | November 30, 2004 |
| Recall Status1 |
Terminated 3 on January 31, 2005 |
| Recall Number | Z-0268-05 |
| Recall Event ID |
30445 |
| Product Classification |
System, Test, Automated, Antimicrobial Susceptibility, Short Incubation - Product Code LON
|
| Product | BD Phoenix ID/AST panels, catalog numbers 448007, 448008, 448400, 448452, 448459, 448600, and 448708, packaged in cartons of 25 panels. |
| Code Information |
Lots: 3316699 11/30/2004 4146868 05/31/2005 4063959 03/31/2005 4231466 08/31/2005 3288384 10/31/2004 3316697 11/30/2004 4035990 02/28/2005 4063276 03/31/2005 4133618 05/31/2005 4203249 07/31/2005 4209161 08/31/2005 4245919 09/30/2005 4231472 08/31/2005 4181008 07/31/2005 4224731 08/31/2005 4231473 08/31/2005 4224708 08/31/2005 |
| FEI Number |
1119779
|
Recalling Firm/ Manufacturer |
Becton Dickinson & Co. 7 Loveton Cir Sparks MD 21152-9212
|
| For Additional Information Contact | BD Customer Service 800-675-0908 |
Manufacturer Reason for Recall | The foil pouch containing an in vitro diagnostic test kit for bacteria identification in patient samples may be defective and cause incorrect patient results. |
FDA Determined Cause 2 | Other |
| Action | BD Diagnostic Systems notified end users by letter dated October 2004. The firm''s sales representatives delivered the letters initially on 10/29/04. The letter advises end users to examine identified lots for defects using a diagram provided with the notification and discard any suspect product for replacement. A response form is included with the notification.
|
| Distribution | Product was sold to direct accounts nationwide and to the firm''s affiliate distributors worldwide. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|